Evidence mapPaperPMID 35456919Full record

ReviewInternational journal of molecular sciences2022

Nutraceutical Concepts and Dextrin-Based Delivery Systems.

Gjylije Hoti, Adrián Matencio, Alberto Rubin Pedrazzo, Claudio Cecone, Silvia Lucia Appleton, Yousef Khazaei Monfared, Fabrizio Caldera, Francesco Trotta

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Gjylije HotiDepartment of Chemistry, University of Torino, Via P. Giuria 7, 10125 Torino, Italy.ORCID 0000-0002-0541-980X
Adrián MatencioDepartment of Chemistry, University of Torino, Via P. Giuria 7, 10125 Torino, Italy.ORCID 0000-0001-8203-0673
Alberto Rubin PedrazzoDepartment of Chemistry, University of Torino, Via P. Giuria 7, 10125 Torino, Italy.ORCID 0000-0001-5239-7546
Claudio CeconeDepartment of Chemistry, University of Torino, Via P. Giuria 7, 10125 Torino, Italy.ORCID 0000-0002-2660-9522
Silvia Lucia AppletonDepartment of Chemistry, University of Torino, Via P. Giuria 7, 10125 Torino, Italy.
Yousef Khazaei MonfaredDepartment of Chemistry, University of Torino, Via P. Giuria 7, 10125 Torino, Italy.ORCID 0000-0002-1171-8670
Fabrizio CalderaDepartment of Chemistry, University of Torino, Via P. Giuria 7, 10125 Torino, Italy.ORCID 0000-0003-2581-0555
Francesco TrottaDepartment of Chemistry, University of Torino, Via P. Giuria 7, 10125 Torino, Italy.
University of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nutraceuticals are bioactive or chemical compounds acclaimed for their valuable biological activities and health-promoting effects. The global community is faced with many health concerns such as cancers, cardiovascular and neurodegenerative diseases, diabetes, arthritis, osteoporosis, etc. The effect of nutraceuticals is similar to pharmaceuticals, even though the term nutraceutical has no regulatory definition. The usage of nutraceuticals, to prevent and treat the aforementioned diseases, is limited by several features such as poor water solubility, low bioavailability, low stability, low permeability, low efficacy, etc. These downsides can be overcome by the application of the field of nanotechnology manipulating the properties and structures of materials at the nanometer scale. In this review, the linear and cyclic dextrin, formed during the enzymatic degradation of starch, are highlighted as highly promising nanomaterials- based drug delivery systems. The modified cyclic dextrin, cyclodextrin (CD)-based nanosponges (NSs), are well-known delivery systems of several nutraceuticals such as quercetin, curcumin, resveratrol, thyme essential oil, melatonin, and appear as a more advanced drug delivery system than modified linear dextrin. CD-based NSs prolong and control the nutraceuticals release, and display higher biocompatibility, stability, and solubility of poorly water-soluble nutraceuticals than the CD-inclusion complexes, or uncomplexed nutraceuticals. In addition, the well-explored CD-based NSs pathways, as drug delivery systems, are described. Although important progress is made in drug delivery, all the findings will serve as a source for the use of CD-based nanosystems for nutraceutical delivery. To sum up, our review introduces the extensive literature about the nutraceutical concepts, synthesis, characterization, and applications of the CD-based nano delivery systems that will further contribute to the nutraceutical delivery with more potent nanosystems based on linear dextrins.

Indexed as

CyclodextrinsDextrinsBiological AvailabilityDietary SupplementsDrug Delivery SystemsWaterCyclodextrinsDextrinsWatercyclic dextrindiseasedrug deliverylinear dextrinnano-carriernanospongesnutraceutical deliverynutraceuticalsstarch

Identifiers

PMID35456919
PMCPMC9031143
OpenAlexW4224234550

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.